Arteriosclerosis, Thrombosis, and Vascular Biology
Academic journal / From Wikipedia, the free encyclopedia
Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.
Discipline | Cardiology, cardiovascular biology |
---|---|
Language | English |
Edited by | Alan Daugherty |
Publication details | |
Former name(s) | Arteriosclerosis; Arteriosclerosis and Thrombosis |
History | 1981–present |
Publisher | |
Frequency | Monthly |
Hybrid | |
10.514 (2021) | |
Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt ) | |
ISO 4 | Arterioscler. Thromb. Vasc. Biol. |
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
CODEN | ATVBFA |
ISSN | 1079-5642 (print) 1524-4636 (web) |
LCCN | 95644718 |
OCLC no. | 31441121 |
Links | |
The journal was established in 1981 as Arteriosclerosis (ISSN 0276-5047), which was published bimonthly. From 1991 to 1994 it was published monthly under the title Arteriosclerosis and Thrombosis: A Journal of Vascular Biology (ISSN 1049-8834).[1]
According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311,[2] ranking it 8th in the category "Hematology"[2] and 5th in the category "Peripheral Vascular Disease".[2] Alan Daugherty has been the editor-in-chief since 2012.[3]